References
- Bonati M, Jacqz-Aigrain E, Choonara I. Licensed medicines, off-label use or evidence-based. Which is most important?. Arch Dis Child. 2016;0:1–2.
- http://www.who.int/medicines/areas/quality_safety/safety_efficacy/Pharmacovigilance_B.pdf
- Pal SN, Duncombe C, Falzon D, et al. WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems. Drug Saf. 2013;36:75–81.
- Impicciatore P, Choonara I, Clarkson A, et al. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol. 2001;52:77–83.
- Benkirane R, Soulaymani-Bencheikh R, Khattabi A, et al. Assessment of a new instrument for detecting preventable adverse drug reactions. Drug Saf. 2015;38:383–393.
- Kimland E, Rane A, Ufer M, et al. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001. Pharmacoepidemiol Drug Saf. 2005;14:493–499.
- Ufer M, Kimland E, Bergman U. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf. 2004;13:147–152.
- Cliff-Eribo KO, Sammons H, Choonara I. Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases. Expert Opin Drug Saf. 2016;15:1321–1328.
- Aldea A, García Sánchez-Colomer M, Fernández Quintana E, et al. Paediatric adverse drug reactions reported to the Spanish pharmacovigilance system from 2004 to 2009. Eur J Clin Pharmacol. 2012;68:1329–1338.
- Aagaard L, Weber CB, Hansen EH. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish medicines agency from 1998 to 2007. Drug Saf. 2010;33:327–339.
- Aagaard L, Hansen EH. Prescribing of medicines in the Danish paediatric population out with the licensed age group: characteristics of adverse drug reactions. Br J Clin Pharmacol. 2011;71:751–757.
- Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol. 2002 Dec;54:665–670.
- Buajordet I, Wesenberg F, Brors O, et al. Adverse drug events in children during hospitalization and after discharge in a Norwegian university hospital. Acta Paediatr. 2002;91:88–94.
- Hawcutt DB, Mainie P, Riordan A, et al. Reported paediatric adverse drug reactions in the UK 2000-2009. Br J Clin Pharmacol. 2012;73:437–446.
- Rosli R, Ming LC, Abd Aziz N, et al. A retrospective analysis of spontaneous adverse drug reactions reports relating to paediatric patients. PLoS One. 2016;11:e0155385.
- Guidelines for ATC classification and DDD assignment 2013. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2012.
- Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (meddra). Drug safety. 1999;20(2):109–117. doi:10.2165/00002018-199920020-00002
- http://www.who.int/medicines/publications/essentialmedicines/Promotion_safe_med_childrens.pdf?ua=1
- Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–245.
- https://www.micromedexsolutions.com/home/dispatch/ssl/true
- The Italian national institute of statistics. http://www.istat.it/en/
- The croatian bureau of statistics. http://www.dzs.hr/.
- Bárzaga Arencibia Z, López Leyva A, Mejías Peña Y, et al. Pharmacovigilance in children in camagüey province, Cuba. Eur J Clin Pharmacol. 2012;68:1079–1084.
- http://www.ema.europa.eu/docs/en_GB/document_library/Report/2014/04/WC500165780.pdf
- Carnovale C, Brusadelli T, Zuccotti G, et al. The importance of monitoring adverse drug reactions in pediatric patients: the results of a national surveillance program in Italy. Expert Opin Drug Saf. 2014;13(Suppl 1):S1–8.
- Tomić S, Sučić AF, Plazonić A, et al. Regulating medicines in croatia: five-year experience of agency for medicinal products and medical devices. Croat Med J. 2010;51(2):104–112.
- Carnovale C, Conti V, Perrone V, et al. Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches. Eur J Pediatr. 2013;172:1679–1685.
- Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ. 1999;77:3–14.
- Dos Santos BA, Ranieri TS, Bercini M, et al. An evaluation of the adverse reaction potential of three measles-mumps-rubella combination vaccines. Rev Panam Salud Publica. 2002;12:240–246.
- Niebyl J, Simpson J. Glob Libr Women’s Med. .2008. . DOI:10.3843/GLOWM.10096
- Morales-Olivas FJ, Martínez-Mir I, Ferrer JM, et al. Adverse drug reactions in children reported by means of the yellow card in Spain. J Clin Epidemiol. 2000;53:1076–1080.
- Clarkson A, Choonara I. Surveillance for fatal suspected adverse drug reactions in the UK. Arch Dis Child. 2002;87:462–467.
- Kristina Star I, Edwards R, Choonara I. Valproic acid and fatalities in children: a review of individual case safety reports in vigiBase. PLoS One. 2014;9:e108970.
- Leone R, Sottosanti L, Luisa Iorio M, et al. Drug-related deaths: an analysis of the Italian spontaneous reporting database. Drug Saf. 2008;31:703–713.
- Romano A, Mayorga C, Torres MJ, et al. Immediate allergic reactions to cephalosporins: cross-reactivity and selective responses. J Allergy Clin Immunol. 2000;106:1177–1183.
- Romano A, Di Fonso M, Artesani MC, et al. Selective immediate hypersensitivity to ceftazidime. Allergy. 2001;56:84–85.
- Thiessard F, Roux E, Miremont-Salame G, et al. Trends in spontaneous adverse drug reaction reports to the French Pharmacovigilance system (1986–2001). Drug Saf. 2005;28:731–740.
- Moneret-Vautrin DA, Morisset M, Flabbée J, et al. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy. 2005;60:443–451.
- Cliff-Eribo KO, Choonara I, Dodoo A, et al. Adverse drug reactions in Ghanaian children: review of reports from 2000 to 2012 in VigiBase. Expert Opin Drug Saf. 2015;14:1827–1833.
- Li H, Guo XJ, Ye XF, et al. Adverse drug reactions of spontaneous reports in Shanghai pediatric population. PLoS One. 2014;24:9:e89829.
- Kaić B, Gjenero-Margan I, Brzović M, et al. Vaccine regulations in Croatia. Coll Antropol. 2007;31:117–120.
- http://www.epicentro.iss.it/discussioni/vaccinazioni/greco.asp.
- Giambi C, Del Manso M, D’Ancona F, et al. Local representatives for VALORE. Actions improving HPV vaccination uptake - results from a national survey in Italy. Vaccine. 2015;15(33):2425–2431.
- Pellegrino P, Carnovale C, Perrone V, et al. No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus. Eur J Epidemiol. 2013;28:705–707.
- Pellegrino P, Carnovale C, Perrone V, et al. Human papillomavirus vaccine in patients with systemic lupus erythematosus. Epidemiology. 2014;25:155–156.
- Pellegrino P, Perrone V, Pozzi M, et al. The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the vaccine adverse event reporting systems. Immunol Res. 2015;61:90–96.
- Holstiege J, Schink T, Molokhia M, et al. Systemic antibiotic prescribing to paediatric outpatients in 5 European countries: a population-based cohort study. BMC Pediatr. 2014;14:174.
- Clavenna A, Sequi M, Bortolotti A, et al. Determinants of the drug utilization profile in the paediatric population in Italy’s Lombardy region. Br J Clin Pharmacol. 2009;67:565–571.
- Garofalo L, Giuseppe GD, Angelillo IF. Self-medication practices among parents in Italy. Biomed Res Int. 2015;2015:580650.
- Prpic I, Vlahovic-Palcevski V, Skarpa-Prpic I, et al. Analysis of antiepileptic drugs use at a university hospital in Croatia. Eur J Neurol. 2005;12:483–485.
- Putignano D, Clavenna A, Campi R, et al. Antiepileptic drug prescribing for children in Italy. Arch Dis Child. 2016;101:e1.
- Hazell L, Shakir SA. Underreporting of adverse drug reactions: a systematic review. Drug Safety. 2006;29:385–396.
- Aagaard L, Hansen EH. Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs. BMC Clin Pharmacol. 2009;9:4.